Michael J. Lush - Publications

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: July 09, 2025

Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: November 11, 2024

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Journal: Breast cancer research : BCR

Published: August 12, 2024

Evaluating the performance of the Breast and Ovarian Analysis of Disease Incidence Algorithm model in predicting 10-year breast cancer risks in UK Biobank.

Journal: Journal of the National Cancer Institute

Published: July 30, 2024

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

Journal: NPJ breast cancer

Published: July 24, 2024

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Journal: medRxiv : the preprint server for health sciences

Published: March 18, 2024

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Journal: NPJ genomic medicine

Published: March 14, 2024

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2024

Genetics, primary care records and lifestyle factors for short-term dynamic risk prediction of colorectal cancer: prospective study of asymptomatic and symptomatic UK Biobank participants.

Journal: BMJ oncology

Published: January 18, 2024

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Journal: Nature genetics

Published: September 26, 2023

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.

Journal: Cancers

Published: April 17, 2023

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

Journal: Journal of medical genetics

Published: January 26, 2023